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Ramadan fasting is compulsory for all healthy adult Muslims. Although sick people are
exempted from Ramadan fasting, some patients such as hemodialysis patients prefer to
fast during Ramadan. The effect of Ramadan fasting on clinical outcomes and biochemical
markers among hemodialysis patients is not clear. The aim of this study was to examine the
effects of daily Ramadan fasting and partial Ramadan fasting on key biochemical and clini-
cal markers among hemodialysis patients as compared to hemodialysis patients who chose
not to fast during Ramadan.
Methods
A prospective cohort study of 269 end stage renal disease patients were recruited from the
hemodialysis unit in An-Najah National University Hospital, Nablus, Palestine. The partici-
pants were divided into three cohorts based on their plans for fasting during Ramadan in
May 2018; Ramadan fasting group (RFG), Ramadan partial fasting group (RPFG) and
Ramadan not-fasting group (RNFG). Key clinical and biochemical markers were measured
before, during and after Ramadan.
Results
After adjustment for diabetic and hypertension status and other sociodemographic variables,
RFG had higher mean inter-dialytic weight gain (IDWG) by 0.62 kg than RNFG (95% confi-
dence interval (CI) 0.26, 0.99). RPFG also had slight increase in mean IDWG than RNFG by
0.35 kg (95% CI 0.11, 0.60). Additionally, RFG and RPFG had significant increase in mean
serum potassium as compared to RNFG. Diabetes was independently associated with
increased IDWG by 0.48 kg (0.25, 0.72). Diabetes and hypertension were associated with
some independent changes in biochemical markers, but these were clinically negligible.
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Conclusion
Our findings suggest that Ramadan fasting (fully or partially) is tolerable by hemodialysis
patients and is not associated with important clinical complications. However, these
patients should be made aware of the potential risk of fluid overload and hyperkalemia,
if they decide to fast during Ramadan. Thus, they should be closely monitored and
instructed to adhere to their dietary and fluid intake allowances. Further prospective
cohort studies with comprehensive dietary measures and information on adverse clinical
outcomes may provide more evidence about the tolerability and safety of Ramadan fast-
ing by hemodialysis patients.
Introduction
Ramadan is the ninth month of the Islamic lunar calendar during which all healthy adult
Muslims are required to abstain from eating any food and drinks from dawn to sunset, with
special exceptions for those severely ill, menstruating females, pre-pubertal children and
travelers [1–3]. The effect of Ramadan fasting on physiological and biomedical markers
among healthy individuals has been widely studied. Research evidence suggests that Rama-
dan fasting is tolerable and safe for healthy adults [3–9]. Ramadan fasting was found to be
associated with beneficial effect on the lipids profile, fasting blood glucose, and body weight
among healthy subjects [10–13]. Other studies reported that Ramadan fasting is not associ-
ated with significant adverse effects on function of different body systems [14, 15]. Despite
the fact that Islam permits sick people and those with significant health problems not to fast
[11], many patients still prefer to fast during Ramadan. Several studies have examined the
effect of Ramadan fasting on physiological and biomedical markers in patients with kidney
diseases. Ramadan fasting was not associated with significant adverse effects in kidney trans-
plant patients after one year of kidney transplantation [16], or urinary risk factors for calcu-
lus formation [17]. However, research findings on the safety of Ramadan fasting by patients
with chronic kidney disease (CKD) on maintenance hemodialysis are mixed and controver-
sial [18, 19]. Some studies have reported that Ramadan fasting was associated with significant
changes in clinical and biomedical markers, such as fluid overload and hyperkalemia, but
with no significant complications requiring hospitalization [3, 20]. Other studies found no
clinically important variations in biomedical markers in hemodialysis patients during Rama-
dan fasting [21, 22]. Due to the lack of clear evidence about the safety of Ramadan fasting by
CDK and hemodialysis patients, the International Diabetes Federation and Ramadan Inter-
national Alliance consider these patients to be at very high risk, and are, therefore, exempted
from Ramadan fasting. Despite this, the literature suggests that significant proportions of
hemodialysis patients still decide to fast during Ramadan. For example, one large multicenter
study in Egypt reported that out of 2055 hemodialysis patients 18.5% and 28.4% chose to
fast daily or partially during Ramadan in 2016, respectively [23]. The aim of this prospective
cohort study was to examine effects of daily Ramadan fasting and partial Ramadan fasting on
key biochemical and clinical markers among hemodialysis patients as compared to hemodi-
alysis patients who chose not to fast during Ramadan. We hypothesize that Ramadan fasting
is tolerable by hemodialysis patients and is not associated with significant changes in bio-
chemical markers.
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Materials and methods
Study design, setting, and population
This prospective cohort study was conducted between April and July 2018 at the Dialysis
Center of An-Najah National University Hospital, Nablus, Palestine. This hemodialysis unit
is the largest dialysis center in the region with more than 320 patients receiving hemodialysis
and peritoneal dialysis therapy. All participants were end-stage renal disease patients aged
18 years or older, who were on regular hemodialysis, three times per week with an average
of 4 hours per session. Ramadan fasting days in 2018 occurred between May 16th, 2018 and
June 14th, 2018. The average fasting hours was about 16 hours with an average temperature
of 27 degrees Celsius. All participants provided written informed consent for participation
in the study. The Institutional Review Board of An-Najah National University approved the
study.
In April 2018, we invited patients to participate in the study and asked them about their
plans for fasting in Ramadan. Then patients who agreed to participate in the study were
grouped into three cohorts. The first cohort included those who planned to fast daily during
Ramadan (Ramadan Fasting Group (RFG)). The second cohort included those who decided
to fast daily during Ramadan excluding hemodialysis days (Ramadan partially fasting group
(RPFG)). The third cohort included patients who decided not to fast during Ramadan and
continued their dietary habits as usual (Ramadan non-fasting group (RNFG)). The patients
were informed to continue their own medications and dietary habits/restrictions during the
period of the study.
Data collection
Demographic and clinical characteristics were collected from patients and their medical rec-
ords. These included age, gender, number of years on hemodialysis, diabetic status (yes, no),
hypertension status (yes, no), inter-dialytic weight gain (IDWG), and education level (primary
education, secondary education, college). The biochemical parameters were: serum levels of
potassium, phosphorus, albumin, calcium, sodium, blood urea nitrogen (BUN), creatinine,
hemoglobin, platelets and erythrocytes count. The biochemical measurements were collected
one month prior to Ramadan fasting. The biochemical measurements were then collected dur-
ing the second week of Ramadan and two weeks after the end of Ramadan. All biochemical
parameters were collected before the start of the hemodialysis session on the three data collec-
tion occasions. All blood samples were sent to the laboratory for analysis immediately after col-
lection and were analyzed on the same day.
Statistical analysis
The biochemical and demographic characteristics of the participants were summarized
using the descriptive statistics. Means with standard deviation (SD) were used to summarize
continuous variables and frequencies with percentages for categorical variables. We used
t-test and χ2 test to examine for any statistically significant differences between the three
cohorts on demographic and clinical characteristics. To account for any within individual
variations in outcome measures, repeated measures analyses using linear mixed-models
were used to examine for any significant differences between the three cohorts in biochemi-
cal parameters before, during and after Ramadan. All outcome variables were normally dis-
tributed and no data transformation was needed. Any p-value less than 0.05 is considered to
be statistically significant and all analyses were conducted using the SPSS computer software
version 23.0 (IBM Corp).
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Results
Baseline characteristics of patients
Two hundred sixty-nine patients were enrolled and all of them completed the study. Thirty-
one patients were in the RFG, one-hundred and two patients were in the RPFG, and the
remaining one-hundred and thirty-six patients were in the RNFG. All patients completed the
study without any changes to their original Ramadan fasting group choice. The mean age of
participants was 57.5 years (SD = 13.6) and 151 patients (56.1%) were males. About 45.7%
(n = 123) and 41.3% (n = 111) had diabetes and hypertension, respectively. The mean duration
on hemodialysis was 3.2 years (SD = 3.7). The baseline demographic and clinical characteris-
tics of patients by Ramadan fasting group are summarized in Table 1. There were no signifi-
cant differences between Ramadan fasting groups according to age, gender, duration on
hemodialysis, and hypertension status. However, there were statistically significant differences
between groups according to diabetic status and education level. RNFG had a higher propor-
tion of diabetic patients (58.1%) than RFG (38.7%) and RPFG (31.6%). RFG and RPFG had
slightly higher education level than RNFG.
Effect of Ramadan fasting on biochemical parameters
After adjustment for diabetes and hypertension status and other statistically significant demo-
graphic variables, RFG had higher mean IDWG by 0.62 kg than RNFG (95% CI 0.26, 0.99; p
0.001). RPFG had slightly higher mean IDWG by 0.23 kg than RNFG, (95% CI 0.11, 0.60; p
0.005). RPFG had increased serum creatinine by 0.77 mg/dl than RNFG (95% CI 0.30, 124; p
0.001), but no significant difference in serum creatinine was found between RFG and RNFG
(Table 2). RFG had higher mean serum potassium than RNFG by 0.48 mEq/L (0.26, 0.70; p
<0.001), but there was no significant difference in mean serum potassium between RPFG and
RNFG.
Independent effects of diabetes and hypertension on biochemical variables
Diabetic status was a significant predictor of a number changes in biochemical parameters
independent of Ramadan fasting. Diabetic patients had high mean IDWG by 0.48 kg than
Table 1. Baseline demographic and biomedical characteristics of hemodialysis patients by Ramadan fasting group.
Variable RFG (n = 31) RPFG (n = 102) RNFG (n = 136) P-value
Age 56.9 (11.5) 55.2 (14.1) 59.4 (13.4) 0.064
Gender
Female 10 (32.3) 42 (41.2) 66 (48.5) 0.202
Male 21 (67.7) 60 (58.8) 70 (51.5)
Education level
Primary school 26 (83.9) 76 (74.5) 123 (90.4) 0.009
Secondary school 3 (9.7) 23 (22.5) 11 (8.1)
College 2 (6.5) 3 (2.9) 2 (1.5)
Duration on dialysis (years) 2.4 (2.6) 3.7 (3.8) 3.0 (3.8) 0.202
Diabetic Mellitus status
No 19 (61.3) 70 (68.4) 57 (41.9) <0.001
Yes 12 (38.7) 32 (31.6) 79 (58.1)
Hypertension status
No 18 (58.1) 63 (61.8) 77 (56.6) 0.725
Yes 13 (41.9) 39 (38.2) 59 (43.4)
Data is either Mean (Standard deviation) or Frequency (%). RFG, Ramadan fasting group; RPFG, Ramadan partial fasting group; RNFG, Ramadan non-fasting group.
https://doi.org/10.1371/journal.pone.0218745.t001
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Table 2. Adjusted� effects of Ramadan fasting on clinical and biochemical parameters.
Biochemical variable Predictor Variable Effect estimate (95% CI) SE of effect estimate Mean (95% CI) SE of mean P-value
Inter-dialytic weight gain (kg) Intercept 4.25 (3.70, 4.81) 0.28 - - < .001
Group
RFG 0.62 (0.26, 0.99) 0.19 3.80 (3.49, 4.15) 0.17 0.001
RPFG 0.35 (0.11, 0.60) 0.13 3.55 (3.37, 3.74) 0.09 0.005
RNFG Ref - 3.20 (3.04, 3.36) 0.08
Diabetic status
No Ref - 3.25 (3.07, 3.43) 0.09
Yes 0.48 (0.25, 0.72) 0.12 3.74 (3.56, 3.92) 0.09 <0.001
Hypertension status
No Ref - 3.45 (3.28, 3.62) 0.08
Yes 0.18 (0.05, 0.41) 0.12 3.63 (3.44, 3.82) 0.09 0.123
Albumin g/dl Intercept 4.03 (3.83, 4.22) 0.10 - - <0.001
Group
RFG 0.05 (-0.08, 0.18) 0.06 3.82 (3.70, 3.93) 0.06 0.448
RPFG 0.08 (-0.01, 0.17) 0.04 3.85 (3.79, 3.92) 0.03 0.055
RNFG Ref - 3.77 (3.71, 3.82) 0.03
Diabetic status
No Ref - 3.87 (3.81, 3.93) 0.03
Yes 0.12 (0.04, 0.20) 0.04 3.75 (3.69, 3.82) 0.03 0.004
Hypertension status
No Ref - 3.77 (3.71, 3.82) 0.03
Yes 0.09 (0.01, 0.17) 0.04 3.86 (3.79, 3.92) 0.03 0.026
Creatinine mg/dl Intercept 10.11 (9.05, 11.18) 0.54 - - <0.001
Group
RFG 0.31 (-0.38, 1.01) 0.35 8.14 (6.99, 9.29) 0.58 0.378
RPFG 0.77 (0.30, 1.24) 0.24 8.55 (7.91, 9.20) 0.33 0.001
RNFG Ref - 8.11 (7.55, 8.67) 0.28
Diabetic status
No Ref - 8.39 (7.76, 9.01) 0.33
Yes -0.52 (-0.97, -0.07) 0.23 8.14 (7.50, 8.78) 0.32 0.023
Hypertension status
No Ref - 3.87 (3.81, 3.93) 0.03
Yes 0.72 (0.28, 1.16) 0.22 3.75 (3.69, 3.82) 0.03 0.001
Blood urea nitrogen mg/dl Intercept 66.42 (59.50, 73.34) 3.51 - - <0.001
Group
RFG 2.09 (-2.36, 6.54) 2.25 58.51 (54.51, 62.52) 2.04 0.355
RPFG 2.36 (-0.65, 5.37) 1.53 58.78 (56.49, 61.07) 1.16 0.124
RNFG Ref - 56.42 (54.51, 58.34) 0.97
Diabetic status
Yes Ref - 57.53 (55.46, 59.59) 1.05 0.599
No 0.76 (-3.61, 2.09) 1.45 58.29 (55.95, 60.62) 1.19
Hypertension status
No Ref - 55.63 (53.60, 57.65) 1.03 0.001
Yes 4.56 (1.77, 7.34) 1.42 60.19 (57.85, 62.52) 1.19
(Continued)
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Table 2. (Continued)
Biochemical variable Predictor Variable Effect estimate (95% CI) SE of effect estimate Mean (95% CI) SE of mean P-value
Potassium mEq/l Intercept 5.52 (5.18, 5.85) 0.17 - - <0.001
Group
RFG 0.48 (0.26, 0.70) 0.11 5.38 (5.18, 5.58) 0.10 <0.001
RPFG 0.12 (-0.03, 0.27) 0.08 5.03 (4.92, 5.14) 0.06 0.104
RNFG Ref - 4.90 (4.81, 5.00) 0.05
Diabetic status
No Ref - 5.10 (5.00, 5.20) 0.05
Yes 0.01 (-0.14, 0.15) 0.07 5.11 (4.99, 5.22) 0.06 0.931
Hypertension status
No Ref - 4.99 (4.89, 5.09) 0.05
Yes 0.24 (0.10, 0.38) 0.07 5.22 (5.11, 5.34) 0.06 0.001
Phosphorus mg/dl Intercept 5.62 (4.96, 6.28) 0.33 - - <0.001
Group
RFG 0.12 (-0.32, 0.55) 0.22 4.86 (4.47, 5.25) 0.20 0.600
RPFG -0.11 (-0.40, 0.19) 0.15 4.64 (4.41, 4.86) 0.11 0.471
RNFG Ref - 4.74(4.56, 4.93) 0.10
Diabetic status
No Ref - 4.85 (4.65, 5.05) 0.10
Yes -0.20 (-0.48, 0.08) 0.14 4.65 (4.42, 4.87) 0.12 0.154
Hypertension status
No Ref - 4.57 (4.38, 4.77) 0.10
Yes 0.35 (0.08, 0.62) 0.14 4.92 (4.69, 5.15) 0.12 0.012
Calcium mg/dl Intercept 8.33 (7.92, 8.74) 0.21 - - <0.001
Group
RFG 0.22 (-0.05, 0.49) 0.14 9.13 (8.88, 9.37) 0.12 0.103
RPFG 0.01 (-0.17, 0.19) 0.09 8.91 (8.77, 9.05) 0.07 0.914
RNFG Ref - 8.90 (8.79, 9.02) 0.06
Diabetic status
No Ref - 9.03 (8.91, 9.15) 0.06
Yes -0.09 (-0.27, 0.07) 0.09 8.93 (8.79, 9.07) 0.07 0.263
Hypertension status
No Ref - 8.92 (8.79, 9.04) 0.06
Yes 0.13 (-0.04, 0.30) 0.09 9.04 (8.90, 9.19) 0.07 0.137
Sodium mEq/l Intercept 133.94 (132.09, 135.79) 0.93 - - <0.001
Group
RFG -0.72 (-1.92, 0.50) 0.61 136.27 (135.18, 137.36) 0.55 0.247
RPFG -0.48 (-1.30, 0.34) 0.42 136.50 (135.88, 137.13) 0.32 0.252
RNFG Ref - 136.98 (136,46, 137.51) 0.27
Diabetic status
No Ref - 137.73 (138.17, 138.29) 0.29
Yes -2.29 (-3.08, -1.51) 0.40 135.44 (134.80, 136.08) 0.32 <0.001
Hypertension status
No Ref - 136.50 (135.95, 137.05) 0.28
Yes 0.18 (-0.34, 1.30) 0.42 136.67 (136.04, 137.31) 0.32 0.252
(Continued)
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non- diabetic patients (95% CI 0.25, 0.72; p <0.001). Diabetic patients had slightly higher
mean albumin by 0.12 g/dl than non-diabetic patients (95% CI 0.04, 0.20; p 0.004). Mean
serum creatinine was lower in diabetic patients than non-diabetic patients by 0.52 md/dl
(95% CI -0.97, -0.07; p 0.023). Additionally, mean sodium was slightly higher in diabetic
patients than non- diabetic patients by 2.29 mEq/l (95% CI -3.08, -1.51; p <0.001). In addi-
tion, mean hemoglobin was slightly higher in patients with diabetes than non-diabetic
patients by 0.36 g/dl (95% CI 0.06, 0.66; p 0.019). Also, slight decrease in mean platelets by
15.65 1000/μL among diabetic patients as compared to those without diabetes (95% CI
Table 2. (Continued)
Biochemical variable Predictor Variable Effect estimate (95% CI) SE of effect estimate Mean (95% CI) SE of mean P-value
Hemoglobin g/dl Intercept 10.86 (10.51, 11.21) 0.18 - - <0.001
Group
RFG 0.45 (-0.02, 0.92) 0.24 11.27 (10.84, 11.69) 0.22 0.061
RPFG 0.20 (-0.12, 0.52) 0.16 11.02 (10.77, 11.26) 0.12 0.217
RNFG Ref - 10.82 (10.61, 11.02) 0.10
Diabetic status
No Ref - 10.85 (10.64, 11.07) 0.11
Yes 0.36 (0.06, 0.66) 0.15 11.21 (10.96, 11.46) 0.13 0.019
Hypertension status
No Ref - 11.13 (10.92, 11.35) 0.11
Yes -0.20 (-0.50, 0.09) 0.15 10.93 (10.68, 11.18) 0.13 0.177
Erythrocyte count 1000/μL Intercept 3.78 (3.65, 3.91) 0.07 - - <0.001
Group
RFG <0.01 (-0.17, 0.17) 0.09 3.70 (3.54, 3.86) 0.08 0.987
RPFG -0.04 (-0.12, 0.52) 0.06 3.66 (3.57, 3.75) 0.05 0.512
RNFG Ref - 3.70 (3.62, 3.77) 0.04
Diabetic status
No Ref - 3.63 (3.55, 3.71) 0.04
Yes 0.11 (-0.01, 0.22) 0.06 3.74 (3.65, 3.83) 0.05 0.060
Hypertension status
No Ref - 3.66 (3.58, 3.74) 0.04
Yes 0.04 (-0.07, 0.15) 0.06 3.70 (3.61, 3.80) 0.05 0.477
Platelets 1000/μL Intercept 202.78 (186.49, 219.08) 8.28 - - < .001
Group
RFG 1.64 (-21.71, 24.99) 11.86 205.40 (184.34, 226.36) 10.70 0.890
RPFG -5.65 (-21.38, 10.09) 7.99 198.11 (186.11, 210.11) 6.09 0.480
RNFG Ref - 203.76 (193.71, 213.80) 5.10
Diabetic status
No Ref - 194.60 (183.85, 205.35) 5.46
Yes -15.65 (-30.35, -0.95) 7.47 210.25 (198.04, 222.46) 6.20 0.037
Hypertension status
No Ref - 203.86 (193.29, 214.43) 5.37
Yes -2.87 (-11.55, 17.29) 7.32 200.99 (188.79, 213.18) 6.19 0.392
RFG, Ramadan fasting group; RPFG, Ramadan partial fasting group; RNFG, Ramadan non-fasting group; SE, Standard Error; CI, Confidence Interval; Ref, Reference
category.
� Effect estimates are adjusted for statistically significant predictors of clinical and biochemical parameters, including age, gender, duration on hemodialysis, and
education level.
https://doi.org/10.1371/journal.pone.0218745.t002
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-30.35, -0.095; p 0.037). Similarly, hypertensive patients had slight increase in mean albu-
min, creatinine, urea, potassium, and phosphorus levels than patients without hypertension
(Table 2).
Discussion
The aim of this cohort study was to assess the effects of daily Ramadan fasting and partial
Ramadan fasting on key biochemical and clinical markers among hemodialysis patients in
comparison to hemodialysis patients who did not fast during Ramadan. After controlling
for within person variation, sociodemographic and significant comorbidities (diabetic and
hypertension status), we found no clinically significant differences between Ramadan fasting
groups in means of the majority of biochemical variables including serum albumin, creati-
nine, blood urea nitrogen, phosphorus, calcium, sodium, hemoglobin, erythrocytes count,
and platelets count. This accord with the findings of prior studies suggesting that, on average,
Ramadan fasting by hemodialysis patients is not associated with significant clinical changes
in key biochemical parameters [3, 21, 24]. The current study found that RFG and RPFG had
slightly higher mean IDWG by 0.6 kg and 0.4 kg than RNFG, respectively. Prior studies have
shown mixed findings with respect to the effect of Ramadan fasting on IDWG in hemodialy-
sis patients. One study reported that Ramadan fasting was associated with increase in mean
IDWG by 0.6 kg among Saudi hemodialysis patients [20]. Other studies reported that Rama-
dan fasting was associated with either decrease or no significant difference in IDWG [3, 22,
24, 25]. The underlying mechanisms for our observation of increasing mean IDWG in
RFG and RPFG is not clear, as our study did not collect dietary information. However, the
increase in IDWG may be explained by increase in fluid intake by patients after breaking
their fast and during the night [1, 20]. For example, one study reported that some hemodialy-
sis patients consumed over three liters of water and other beverages from sunset to dawn
[20]. Our finding of increased mean IDWG by 0.5 kg in diabetic patients as compared to
patients without diabetes, independent of Ramadan fasting status, may be attributed to oral
dryness and higher hemoglobin A1c level [26]. The present study found a significant increase
in mean serum potassium in RFG than that of RNFG suggesting that hemodialysis patients
fasting daily during Ramadan may be at risk of hyperkalemia. Although, this finding differs
from some previous studies [3, 21–24], which showed no significant changes in serum potas-
sium due to Ramadan fasting in hemodialysis patients, it is consistent with the findings of
another study from KSA by Al-Khader and colleagues [20]. However, no adverse effects
related to hyperkalemia were reported by that study [20]. The reason for increase in serum
potassium in RFG in the current study is not clear. However, one potential explanation is
increased consumption of Ramadan’s festive foods rich in potassium (e.g. dates, apricot,
watermelon, sweets, carbonated soft drinks, squash, tea and coffee), which is traditional in
Palestine and other middle eastern countries [3, 10, 20, 24]. Another explanation is insulin
suppression due to fasting (insuliopenia), causing shift of potassium from the intracellular to
the extracellular space [27, 28].
Although the evidence from this study suggests that Ramadan fasting by hemodialysis
patients is not associated with clinically significant complications, it highlights that these
patients may be at risk of hyperkalemia and fluid overload. Therefore, hemodialysis patients
who intend to fast during Ramadan should be made aware of these potential complications.
Additionally, these patients should be monitored closely for signs and symptoms of hyperkale-
mia and fluid overload. They should also be advised to avoid exceeding their daily fluid allow-
ance and limit their intake of food rich in potassium.
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Strengths and limitations
This study included relatively a large number of patients undergoing hemodialysis at An-Najah
National University Hospital. The number of hemodialysis patients in this unit represents about
20% of all hemodialysis patients in the West Bank, Palestine [29]. So, the demographic, clinical,
and biochemical characteristics of included hemodialysis patients are likely to be generalizable
to hemodialysis population in Palestine. Another important strength of the study is that the
effects of Ramadan fasting on biochemical markers was estimated using RFG, RPFG, and RNFG
cohorts. This information is useful for hemodialysis patients considering full or partial Ramadan
fasting. Another strength is that biochemical markers were measured before, during, and after
Ramadan. Additionally, we used repeated measured with mixed models to account for within-
person variation in biochemical markers, and the findings are independent of key demographic
and clinical characteristics of hemodialysis patients. In addition, our study was conducted in the
summer (May-June, 2018), when the weather is hot and relatively dry in Nablus region, which
provides some reassurance about the tolerability of Ramadan fasting by hemodialysis patients at
this time of the year. However, this may not generalize to other regions with longer duration of
Ramadan fasting and different temperature and humidity conditions. Another important limita-
tion of our study is that we did not measure or account for potential effects of dietary changes
during Ramadan or dietary habits more generally on biochemical markers. One more limitation
is that our study did not collect information on some adverse events (such as emergency visits
or hospital admissions). However, prior studies have shown that occurrence of such adverse
events is low among hemodialysis patients fasting during Ramadan [3, 20, 21]. More research
with appropriate dietary measures and information on adverse events among hemodialysis
patients fasting during Ramadan is needed to help clinicians provide appropriate and safe rec-
ommendations for hemodialysis patients considering full or partial Ramadan fasting.
Conclusions
This study adds further evidence that Ramadan fasting, fully or partially, is tolerable and is
not associated with significant clinical complications in hemodialysis patients. However, these
patients are at risk of fluid overload and hyperkalemia. Therefore, they should be closely moni-
tored and instructed to adhere to their daily fluid allowance and limit their consumption of
food rich in potassium. Further prospective cohort studies with dietary and adverse events
measures may provide clearer evidence about the tolerability and safety of full or partial Rama-
dan fasting by hemodialysis patients.
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